BridgeBio Pharma teams with awareness groups to spotlight ATTR-CM’s hidden impact on women

BridgeBio Pharma is teaming up with BlackDoctor and HealthyWomen to highlight how the heart condition ATTR-cardiac amyloidosis (ATTR-CM) is being “systematically missed in women.”

The condition is a potentially fatal disease of the heart muscle in which the protein transthyretin becomes misshapen and builds up in the heart, nerves and other organs.

When these protein deposits accumulate in the heart, the walls can become stiff. As the condition worsens, the heart can struggle to pump blood, potentially leading to heart failure.